Literatur
- 1
Robertson B, Speer C P.
Henry L. Halliday - master of evidence-based neonatology.
Biol Neonate.
2005;
88
245-247
- 2
Post M.
General concepts of lung development: implications for disease.
Biol Neonate.
2005;
88
248
- 3
Whitsett J A.
Surfactant proteins in innate host defense of the lung.
Biol Neonate.
2005;
88
175-180
- 4
Soll R F.
Update on surfactant therapy: recent reviews in the cochrane library.
Biol Neonate.
2005;
88
249-250
- 5
Curstedt T.
New synthetic surfactants for clinical use.
Biol Neonate.
2005;
88
250-251
- 6
Rabinovitch M.
Signaling pathways and the pathobiology of pulmonary hypertension.
Biol Neonate.
2005;
88
251-252
- 7
Abman S H, Balasubramaniam V, Kinsella J P.
Roles of nitric oxide in the pathobiology and treatment of bronchopulmonary dysplasia.
Biol Neonate.
2005;
88
252-253
- 8
Morley C J.
Neonatal stabilisation (resuscitation): learning from video and physiological recordings.
Biol Neonate.
2005;
88
253-254
- 9
Carlo W A.
Ventilatory strategies to prevent lung injury.
Biol Neonate.
2005;
88
254-255
- 10
Bland R D.
Neonatal chronic lung disease in the post-surfactant era.
Biol Neonate.
2005;
88
181-191
- 11
Bancalari E, Claure N, Gonzales A.
Patent ductus arteriosus and respiartory outcome in premature infants.
Biol Neonate.
2005;
88
192-201
- 12
Kramer B W, Jobe A H.
The clever fetus: responding to inflammation to minimize lung injury.
Biol Neonate.
2005;
88
202-207
- 13
Shinwell E S.
Benefits and risks of dexamethasone and hydrocortisone in the preterm infant.
Biol Neonate.
2005;
88
255-257
- 14
Gluckman P D, Vickers M, Hofman P, Cutfield W.
Life-long echoes - the developmental origins of health and disease in later life.
Biol Neonate.
2005;
88
257
- 15
Saliba E, Cantagrel S, Chalon S.
Hypoxic-ischemic brain injury in the term infant: current concepts.
Biol Neonate.
2005;
88
258-259
- 16
Dammann O.
Inflammatory brain damage in the preterm newborn: etiologic and pathogenetic aspects.
Biol Neonate.
2005;
88
259-260
- 17
Whitelaw A.
Hydrocephalus after intraventricular haemorrhage: mechanisms and treatment.
Biol Neonate.
2005;
88
260
- 18
Schmidt B.
Methylxanthine therapy for apnea of prematurity: evaluation of treatment benefits
and risks at age 5 years in the international caffeine and apnea of prematurity (CAP)
trial.
Biol Neonate.
2005;
88
208-213
- 19
Ng P C.
Transient adrenocortical insufficiency of prematurity - TAP.
Biol Neonate.
2005;
88
261-262
- 20
Satwani P, Morris E, van de Ven C, Cairo M S.
Dysregulation of expression of immunoregulatory and cytokine genes and its association
with the immaturity in neonatal phagocytic and cellular immunity.
Biol Neonate.
2005;
88
214-227
- 21
Philip A GS.
Neonatal sepsis: are we doing better?.
Biol Neonate.
2005;
88
262-263
- 22
Tin W.
Oxygen therapy in preterm babies: fifty years of uncertainty.
Biol Neonate.
2005;
88
263-264
- 23
Saugstad O.
Oxidative stress in the newborn - a 30 years perspective.
Biol Neonate.
2005;
88
228-236
- 24
Smith L EH.
IGF-1 and retinopathy of prematurity in the preterm infant.
Biol Neonate.
2005;
88
237-244
- 25
Hoath S B, Narendran V, Visscher M O.
Vernix, amniotic fluid, and neonatal skin.
Biol Neonate.
2005;
88
265-266
- 26
Cooke R J.
Advances in neonatal nutrition: food for thought and indigestion.
Biol Neonate.
2005;
88
267
Dr. Boris W. Kramer
Universitäts-Kinderklinik
Josef-Schneider-Str. 2
97080 Würzburg
Telefon: 0931-201-27102
Fax: 0931-201-27242
eMail: kramer_b@kinderklinik.uni-wuerzburg.de
